SARS-CoV-2 replicon for high-throughput antiviral screening.
J Gen Virol
; 102(5)2021 05.
Article
in En
| MEDLINE
| ID: mdl-33956592
Full text:
1
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Replicon
/
Drug Evaluation, Preclinical
/
SARS-CoV-2
Type of study:
Diagnostic_studies
/
Screening_studies
Language:
En
Journal:
J Gen Virol
Year:
2021
Type:
Article